Carrillo ER, Carrillo CJR, Carrillo CLD

Language: Spanish
References: 17
Page: 43-50
PDF size: 228.12 Kb.

ABSTRACT

Severe sepsis is common. 750,000 cases are estimated to occur annually in the United States. The mortality rate for severe sepsis still ranges from 30 to 50%, and is as high as 80 to 90% for septic shock and multiple organ dysfunction. Severe sepsis exists along a continuum initiated by a localized infection that triggers a systemic inflammatory response. A cascade of inflammation and activation of the coagulation system associated with impaired fibrinolysis leads to alterations in microvascular circulation associated with organ dysfunction, severe sepsis, multiple organ dysfunction syndrome, and death. Treatment guidelines that are evidence-based and endorsed by 11 professional societies representing multispecialty groups are described. In an attempt to improve care and reduce mortality, the Surviving Sepsis Campaign and The Institute for Healthcare Improvement (IHI) have created two sepsis treatment bundles. In this paper we review and describe the sepsis treatment bundles.

REFERENCES

1. Dellinger RP, Carlet JM, Masur H. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73.

2. Dellinger RP, Carlet JM, Masur H. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004;30:536-55.

3. Cabana MD, Rand CS, Powe NR. Why don‘t physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-65.

4. Levy MM, Provonost PJ, Dellinger RP. Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med 2004;32:595-7.

5. Gao F, Melody T, Daniels DF. The impact of compliance with

6. 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care 2005;9:764-70.

7. Bakker J, Coffernils M, Leon M. Blood lactate levels are superior to oxygen derived variables in predicting outcome in human septic shock. Chest 1991;99:956-62.

8. FriedmanG, Berlot G, Kahn RJ. Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis. Crit Care Med 1995;23:1184-93.

9. Bochud PY, Bonten M, Marchetti O. Antimicrobial therapy for patients with severe sepsis and septic shock: an evidencebased review. Crit Care Med 2004;32:495-512.

10. Cohen J, Brun-Buisson C, Torres A. Diagnosis of infection in sepsis: an evidence-based review. Crit Care Med 2004;32:466-94.

11. Ibrahim EH, Sherman G, Ward S. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118:146-55.

12. Kollef MH, Sherman G, Ward S. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-74.

13. Rivers E, Nguyen B, Havstad S. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.

14. Reinhart K, Kuhn HJ, Hartog C. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med 2004;30:1572-8.

15. Choi PT, Yip G, Quinonez LG. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999;27:200-10.

16. Finfer S, Bellomo R, Boyce N. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-56.

17. Beale RJ, Hollenberg SM, Vincent JL. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med 2004;32:455-65.